| 1 | Bezafibrate | 1件: BezafibrateBezafibrate (Bezafibrate) | 1件: BezafibrateBezafibrate
                
             (Bezafibrate) 💬 | 1件: PPARAPPARA 💬 | 10件: Adipocytokine signaling pathwayAdipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 7件: 2020, 93, 94, 160, 296, 316, 324 💬 | 
| 2 | Bezafibrate (400mg) in addition to standard 15-20 mg/kg/jour UDCA therapy | 2件: BezafibrateBezafibrate (Bezafibrate), Ursodeoxycholic acid
 | 2件: UrsodiolUrsodiol
                
            , Bezafibrate
                
             (Bezafibrate) 💬
 | 2件: NR1H4NR1H4, PPARA 💬
 | 11件: Adipocytokine signaling pathwayAdipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件: 9494 💬 | 
| 3 | Bezafibrate (drug) | 1件: BezafibrateBezafibrate (Bezafibrate) | 1件: BezafibrateBezafibrate
                
             (Bezafibrate) 💬 | 1件: PPARAPPARA 💬 | 10件: Adipocytokine signaling pathwayAdipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件: 316316 💬 | 
| 4 | Bezafibrate (INN 3968) | 1件: BezafibrateBezafibrate (Bezafibrate) | 1件: BezafibrateBezafibrate
                
             (Bezafibrate) 💬 | 1件: PPARAPPARA 💬 | 10件: Adipocytokine signaling pathwayAdipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件: 324324 💬 | 
| 5 | Bezafibrate 200 MG | 1件: BezafibrateBezafibrate (Bezafibrate) | 1件: BezafibrateBezafibrate
                
             (Bezafibrate) 💬 | 1件: PPARAPPARA 💬 | 10件: Adipocytokine signaling pathwayAdipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件: 9393 💬 | 
| 6 | Bezafibrate 200 MG Oral Tablet | 1件: BezafibrateBezafibrate (Bezafibrate) | 1件: BezafibrateBezafibrate
                
             (Bezafibrate) 💬 | 1件: PPARAPPARA 💬 | 10件: Adipocytokine signaling pathwayAdipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件: 9393 💬 | 
| 7 | Bezafibrate 400 MG | 1件: BezafibrateBezafibrate (Bezafibrate) | 1件: BezafibrateBezafibrate
                
             (Bezafibrate) 💬 | 1件: PPARAPPARA 💬 | 10件: Adipocytokine signaling pathwayAdipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件: 9393 💬 | 
| 8 | Bezafibrate IR | 1件: BezafibrateBezafibrate (Bezafibrate) | 1件: BezafibrateBezafibrate
                
             (Bezafibrate) 💬 | 1件: PPARAPPARA 💬 | 10件: Adipocytokine signaling pathwayAdipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件: 9393 💬 | 
| 9 | Bezafibrate SR | 1件: BezafibrateBezafibrate (Bezafibrate) | 1件: BezafibrateBezafibrate
                
             (Bezafibrate) 💬 | 1件: PPARAPPARA 💬 | 10件: Adipocytokine signaling pathwayAdipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件: 9393 💬 | 
| 10 | Bezafibrate, Beza, BZF, Bezalip | 1件: BezafibrateBezafibrate (Bezafibrate) | 1件: BezafibrateBezafibrate
                
             (Bezafibrate) 💬 | 1件: PPARAPPARA 💬 | 10件: Adipocytokine signaling pathwayAdipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件: 9393 💬 | 
| 11 | Bezafibrate, Beza, BZF, Bezalip mono | 1件: BezafibrateBezafibrate (Bezafibrate) | 1件: BezafibrateBezafibrate
                
             (Bezafibrate) 💬 | 1件: PPARAPPARA 💬 | 10件: Adipocytokine signaling pathwayAdipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件: 9393 💬 |